跳至主要内容
临床试验/NCT01830933
NCT01830933已完成不适用

Breast Cancer Risk Reduction: A Patient Doctor Intervention

University of California, San Francisco2 个研究点 分布在 1 个国家目标入组 1,235 人开始时间: 2011年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
1,235
试验地点
2
主要终点
Knowledge of Breast Cancer Risk Factors

研究概览

简要总结

The proposed research combines the scientific advances in breast cancer research with health information technology (IT) to design a personalized intervention that assesses breast cancer risk for women, disseminates important breast health information, and facilitates discussion of breast cancer risk reduction practices. Our goal is to implement a tablet-PC (personal computer) based breast cancer risk education (BreastCare) intervention in the primary care setting that estimates a woman's individual risk for breast cancer and provides her and her physician with personalized breast cancer risk information and recommendations for action.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
40 Years 至 74 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patient component:
  • •Women who visit the General Internal Medicine (GIM) practices at SFGH and UCSF during the study period
  • •Between the ages of 40 and 74
  • •Self-identify as Asian American, Spanish- and English-speaking Latinas, African American, or White
  • •Have no history of breast cancer are eligible to participate.
  • •Physician component: Primary care physicians currently practicing at the GIM clinics at SFGH and UCSF

排除标准

  • •Patient component: Women whose physicians object to their participation in the study
  • •Physician component: No exclusion criteria for physicians

研究组 & 干预措施

BreastCARE Intervention

Experimental

Intervention Clinic Patients: The RA will welcome the patient upon arrival at the clinic and again explain study procedures and field any questions. The RA will have the patient sign the HIPAA authorization form and then demonstrate how to enter information and answer questions on the tablet-PC and the patient will indicate their consent electronically before beginning the assessment.

Intervention Patient Report. Once the patient completes the BreastCare Computer survey, the program will immediately generate a personal feedback report containing information about her risk factors and recommendations to reduce her risk. This report will be printed and given to the patietns before she meets with her doctor.

干预措施: BreastCARE (Other)

BreastCARE Comparison

No Intervention

Patients will be randomized into the intervention or comparison groups at the time of recruitment. Block-randomization will be used to assign patients to intervention or comparison groups.

Comparison Clinic Patients. Contact and baseline interview procedures will be the same for patients from the comparison clinics, however there will be no computer assessment at the time of their clinic visit. An RA will meet the patient 10 minutes prior to her appointment time to obtain written HIPAA authorization.

结局指标

主要结局

Knowledge of Breast Cancer Risk Factors

时间窗: one week post-initial visit (approximately one week)

Risk knowledge was assessed using a post-survey. Participants could have scored 0-100 (with 0 meaning no correct answers, and 100 is all correct answers). This outcome was measured through a survey. Breast cancer risk knowledge was based on a series of eight questions in the survey. O

Percentage of Participants Who Reported Discussion of Mammography Screening

时间窗: up to 14 months

Self reported discussion of mammography with physician.

Percentage of Participants With Correct Perception of Risk

时间窗: baseline, one week post-initial visit (approximately one week)

This outcome was measured through a survey. Women were asked what they thought about their risk of getting breast cancer was compared to other women of the same age.

Percentage of Participants Who Had a Discussion of Breast Cancer Risk

时间窗: one week post-initial visit (approximately one week)

Self-reported discussion of breast cancer risk with physicians.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验